Diagnostic Value of sTREM-1 in Bronchoalveolar Lavage Fluid in ICU Patients With Bacterial Lung Infections: A Bivariate Meta-Analysis

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Shi, Jia Xin ^a   Li, Jia Shu ^a   Hu, Rong ^a   Li, Chun Hua ^a   Wen, Yan ^a   Zheng, Hong ^a   Zhang, Feng ^a   Li, Qin ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1;

ARTICLE; BACTERIAL INFECTION; BACTERIAL PNEUMONIA; BACTERIUM CULTURE; COMMUNITY ACQUIRED PNEUMONIA; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; HOSPITAL ACQUIRED PNEUMONIA; HUMAN; IMMUNOBLOTTING; INTENSIVE CARE UNIT; LUNG INFECTION; LUNG LAVAGE; META ANALYSIS; PULMONARY ASPIRATION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; VENTILATOR ASSOCIATED PNEUMONIA;

BACTERIAL INFECTIONS; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; HUMANS; INTENSIVE CARE UNITS; LUNG DISEASES; MEMBRANE GLYCOPROTEINS; RECEPTORS, IMMUNOLOGIC; ROC CURVE;

BACTERIA (MICROORGANISMS);

EID: 84878471379     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065436     Document Type: Article

References (31)

1. Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, et al. (1995) The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 274: 639-644.
2. Iregui M, Ward S, Sherman G, Fraser VJ, Kollef MH, (2002) Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 122: 262-268.
3. Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY, (2006) Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 34: 1996-2003.
4. Gibot S, Cravoisy A, Levy B, Bene MC, Faure G, et al. (2004) Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N Engl J Med 350: 451-458.
5. Conway Morris A, Kefala K, Wilkinson TS, Moncayo-Nieto OL, Dhaliwal K, et al. (2010) Diagnostic importance of pulmonary interleukin-1beta and interleukin-8 in ventilator-associated pneumonia. Thorax 65: 201-207.
6. Srinivasan R, Song Y, Wiener-Kronish J, Flori HR, (2011) Plasminogen activation inhibitor concentrations in bronchoalveolar lavage fluid distinguishes ventilator-associated pneumonia from colonization in mechanically ventilated pediatric patients. Pediatr Crit Care Med 12: 21-27.
7. Duflo F, Debon R, Monneret G, Bienvenu J, Chassard D, et al. (2002) Alveolar and serum procalcitonin: diagnostic and prognostic value in ventilator-associated pneumonia. Anesthesiology 96: 74-79.
8. Kofoed K, Andersen O, Kronborg G, Tvede M, Petersen J, et al. (2007) Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study. Crit Care 11: R38.
9. Ramirez P, Kot P, Marti V, Gomez MD, Martinez R, et al. (2011) Diagnostic implications of soluble triggering receptor expressed on myeloid cells-1 in patients with acute respiratory distress syndrome and abdominal diseases: a preliminary observational study. Crit Care 15: R50.
10. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J, (2003) The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 3: 25.
11. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, et al. (2004) Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Fam Pract 21: 4-10.
12. Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, et al. (2005) Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol 58: 982-990.
13. Higgins JP, Thompson SG, (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539-1558.
14. Deeks JJ, Macaskill P, Irwig L, (2005) The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol 58: 882-893.
15. Fagan TJ, (1975) Letter: Nomogram for Bayes theorem. N Engl J Med 293: 257.
16. Oudhuis GJ, Beuving J, Bergmans D, Stobberingh EE, ten Velde G, et al. (2009) Soluble Triggering Receptor Expressed on Myeloid cells-1 in bronchoalveolar lavage fluid is not predictive for ventilator-associated pneumonia. Intensive Care Med 35: 1265-1270.
17. Wu CL, Lu YT, Kung YC, Lee CH, Peng MJ, (2011) Prognostic value of dynamic soluble triggering receptor expressed on myeloid cells in bronchoalveolar lavage fluid of patients with ventilator-associated pneumonia. Respirology 16: 487-494.
18. Man XY, Tong ZH, Huang KW, Pang BS, Zhan QY, et al. (2009) Preliminary evaluation of soluble triggering receptor expressed on myeloid cells-1 in diagnosis of pneumonia. International Journal of Respiration 29: 1473-1476.
19. Wang ZL, Li XD, Hung XB, Zhang XL, Qiu HX, (2012) The clinical significance of detecting the level of bronchoalveolar lavage fluid of sTREM-1 in ventilator-associated pneumonia. Chinese Journal of Medicinal Guide 14: 1014-1015.
20. Determann RM, Millo JL, Gibot S, Korevaar JC, Vroom MB, et al. (2005) Serial changes in soluble triggering receptor expressed on myeloid cells in the lung during development of ventilator-associated pneumonia. Intensive Care Med 31: 1495-1500.
21. Gibot S, Cravoisy A, Dupays R, Barraud D, Nace L, et al. (2007) Combined measurement of procalcitonin and soluble TREM-1 in the diagnosis of nosocomial sepsis. Scand J Infect Dis 39: 604-608.
22. Horonenko G, Hoyt JC, Robbins RA, Singarajah CU, Umar A, et al. (2007) Soluble triggering receptor expressed on myeloid cell-1 is increased in patients with ventilator-associated pneumonia: a preliminary report. Chest 132: 58-63.
23. Huh JW, Lim CM, Koh Y, Oh YM, Shim TS, et al. (2008) Diagnostic utility of the soluble triggering receptor expressed on myeloid cells-1 in bronchoalveolar lavage fluid from patients with bilateral lung infiltrates. Crit Care 12: R6.
24. El Solh AA, Akinnusi ME, Peter M, Berim I, Schultz MJ, et al. (2008) Triggering receptors expressed on myeloid cells in pulmonary aspiration syndromes. Intensive Care Med 34: 1012-1019.
25. Anand NJ, Zuick S, Klesney-Tait J, Kollef MH, (2009) Diagnostic implications of soluble triggering receptor expressed on myeloid cells-1 in BAL fluid of patients with pulmonary infiltrates in the ICU. Chest 135: 641-647.
26. Palazzo SJ, Simpson TA, Simmons JM, Schnapp LM, (2012) Soluble Triggering Receptor Expressed on Myeloid Cells-1 (sTREM-1) as a Diagnostic Marker of Ventilator-Associated Pneumonia. Respir Care 57: 2052-2058.
27. Colonna M, Facchetti F, (2003) TREM-1 (triggering receptor expressed on myeloid cells): a new player in acute inflammatory responses. J Infect Dis 187Suppl 2: S397-401.
28. Kamei K, Yasuda T, Ueda T, Qiang F, Takeyama Y, et al. (2010) Role of triggering receptor expressed on myeloid cells-1 in experimental severe acute pancreatitis. J Hepatobiliary Pancreat Sci 17: 305-312.
29. Mahdy AM, Lowes DA, Galley HF, Bruce JE, Webster NR, (2006) Production of soluble triggering receptor expressed on myeloid cells by lipopolysaccharide-stimulated human neutrophils involves de novo protein synthesis. Clin Vaccine Immunol 13: 492-495.
30. Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PM, (2003) The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 56: 1129-1135.
31. Petitti DB, (2001) Approaches to heterogeneity in meta-analysis. Stat Med 20: 3625-3633.